Allan Marriott-Smith has been appointed as the new Chief Executive of the Human Tissue Authority (HTA). Allan will take up leadership of the regulator for tissue and organs on 6 July.
Allan was previously the HTA’s Director for Strategy and Quality.
Allan Marriott-Smith, the HTA’s new Chief Executive said: “I am delighted to be taking up this important and challenging role within the HTA as the organisation heads into its second decade. I look forward to building on the HTA’s strong reputation for effective, expert regulation in collaboration with our staff, Board and partners. The HTA has a challenging 12 months ahead with plans for two public consultations, further improvements to our licensing and inspection processes, and a Government review of our work. My focus throughout will be making sure we seize every opportunity to build on our strengths and deliver our aims even more effectively over the coming years.”
Sharmila Nebhrajani, the HTA Chair said: “Allan brings with him both broad experience from a range of previous roles, and a close understanding of the policy and strategy environment garnered in his five years at the HTA. His wonderful blend of enthusiasm and expertise will be put to great use in the next 12 months, where we will focus on the upcoming triennial review, the launch of our new Codes of Practice, and our continued work to build public and professional confidence in the safe and ethical use of tissue and organs.”
Allan Marriott-Smith became Chief Executive of the HTA in July 2015. Allan joined the HTA in May 2009, most recently working as Director of Strategy and Quality where he had corporate responsibility for the strategic and business planning process, quality improvement, and the regulation of living donation. Prior to that Allan had worked for a number of years as a government statistician at the UK Statistics Authority.
As the Chief Executive of the HTA, Allan is the Accounting Officer and is responsible for implementing the strategic plan of the organisation. This involves improving the efficiency and effectiveness of regulation, ensuring that the HTA has appropriate and productive relationships with its stakeholders, and leading and managing the skilled and dedicated workforce at the HTA. Allan is also responsible for ensuring that the HTA is governed effectively and provides good value for money.